Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Collegium Pharmaceutical (COLL) Profit After Tax: 2014-2024

Historic Profit After Tax for Collegium Pharmaceutical (COLL) over the last 11 years, with Dec 2024 value amounting to $69.2 million.

  • Collegium Pharmaceutical's Profit After Tax rose 237.51% to $31.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $58.4 million, marking a year-over-year decrease of 34.03%. This contributed to the annual value of $69.2 million for FY2024, which is 43.68% up from last year.
  • Collegium Pharmaceutical's Profit After Tax amounted to $69.2 million in FY2024, which was up 43.68% from $48.2 million recorded in FY2023.
  • Collegium Pharmaceutical's Profit After Tax's 5-year high stood at $71.5 million during FY2021, with a 5-year trough of -$25.0 million in FY2022.
  • In the last 3 years, Collegium Pharmaceutical's Profit After Tax had a median value of $48.2 million in 2023 and averaged $30.8 million.
  • In the last 5 years, Collegium Pharmaceutical's Profit After Tax crashed by 134.96% in 2022 and then soared by 292.60% in 2023.
  • Over the past 5 years, Collegium Pharmaceutical's Profit After Tax (Yearly) stood at $26.8 million in 2020, then surged by 167.33% to $71.5 million in 2021, then slumped by 134.96% to -$25.0 million in 2022, then skyrocketed by 292.60% to $48.2 million in 2023, then surged by 43.68% to $69.2 million in 2024.